InspireMD Inc.

NASDAQ: NSPR · Real-Time Price · USD
2.48
-0.02 (-0.80%)
At close: Aug 15, 2025, 12:52 PM

InspireMD Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7.01M 6.21M 5.17M 4.5M
Cost of Revenue
5.5M 4.4M 4.05M 3.74M
Gross Profit
1.51M 1.81M 1.12M 754K
Operating Income
-33.5M -21.14M -18.71M -14.72M
Interest Income
1.56M 1.29M 250K n/a
Pretax Income
-31.95M -19.85M -18.46M -14.87M
Net Income
-32.01M -19.92M -18.49M -14.92M
Selling & General & Admin
21.38M 14.97M 12.02M 10.31M
Research & Development
13.63M 7.98M 7.81M 5.16M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
35.01M 22.95M 19.83M 15.47M
Interest Expense
n/a n/a n/a 157K
Selling & Marketing Expenses
6.07M 3.87M 3.66M 2.91M
Cost & Expenses
40.51M 27.35M 23.88M 19.21M
Income Tax Expense
59K 65K 28K 45K
Shares Outstanding (Basic)
41.93M 24.27M 7.87M 7.35M
Shares Outstanding (Diluted)
41.93M 24.27M 7.87M 7.35M
EPS (Basic)
-0.76 -0.82 -2.35 -2.03
EPS (Diluted)
-0.76 -0.82 -2.35 -2.03
EBITDA
-33.22M -20.91M -18.52M -14.55M
EBIT
-33.5M -21.14M -18.71M -14.72M
Depreciation & Amortization
280K 232K 188K 161K